January 28, 2011 FDA ECT Summary Report Blind SpotsAt the end of today’s hearings, an FDA advisory panel will issue recommendations about whether manufacturers of Read More FDA ECT Summary Report Blind Spots
December 2, 2010 Why Psychoterapies Never Get BetterTimes reporter, Ben Carey, reported in all seriousness : " In a recent study using [Angelina] this Read More Why Psychoterapies Never Get Better
June 13, 2010 Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide RisksA report in BNET, the business publication, by its pharmaceutical industry analyst, Jim Edwards, reveals that GlaxoSmithKline Read More Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks
December 6, 2006 Another Psych Drug Demonstrated to be USELESS / HARMFUL_Yale /ColumbiaA widely prescribed hypertensive drug for managing high blood pressure, drug for children labeled with ADHD and Read More Another Psych Drug Demonstrated to be USELESS / HARMFUL_Yale /Columbia
November 2, 2006 Separating the Facts from the Propaganda_Latest Findings of Depression StudyThe optimistic headline news reports such as Associated Press/ MSNBC (below) promulgate industry's marketing propaganda by helping Read More Separating the Facts from the Propaganda_Latest Findings of Depression Study
October 26, 2006 Pharma’s Pervasive Influence Corrupts Medicine both sides of AtlanticPharma’s Pervasive Influence Corrupts Medicine both sides of Atlantic Tue, 4 Oct 2005 The focus of criticism Read More Pharma’s Pervasive Influence Corrupts Medicine both sides of Atlantic
October 26, 2006 Antidepressant Use in Children Soars Despite Efficacy Doubts – Washington PostAntidepressant Use in Children Soars Despite Efficacy Doubts – Washington Post Mon, 19 Apr 2004 A front Read More Antidepressant Use in Children Soars Despite Efficacy Doubts – Washington Post
October 26, 2006 Advisory Committee tells FDA: strengthen warnings on SSRI drug labels nowAdvisory Committee tells FDA: strengthen warnings on SSRI drug labels now Wed, 4 Feb 2004 On February Read More Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now
October 26, 2006 Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMACredibility Crisis:Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA Thu, 16 Dec Read More Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA
October 26, 2006 Pharma Efforts to Bar Placebo Responders from Trials – WSJPharma Efforts to Bar Placebo Responders from Trials – WSJ Fri, 25 Jun 2004 A clinical trial Read More Pharma Efforts to Bar Placebo Responders from Trials – WSJ
October 26, 2006 Commonly recommended Treatments found WorthlessCommonly recommended Treatments found Worthless Wed, 19 Mar 2003 Independent analyses of the clinical studies upon which Read More Commonly recommended Treatments found Worthless
October 26, 2006 Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – LeoReply to the American College of Neuropharmacology’s Report on SSRI and Suicidal Behavior in Children Jonathan Leo, Read More Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo
October 26, 2006 Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJNext Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 Read More Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ
October 26, 2006 Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?Are SSRIs and Atypical Antidepressants Safe / Effective for Children / Adolescents/ Neonates? Wed, 2 Mar 2005 Read More Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?